Schedule 13G ownership disclosure
Tarsus Pharmaceuticals Inc
Security class unavailable · CUSIP: 87650L103
Event date: 2020-10-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.7900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-019928
- Form type
- SC 13G
- Filer
- RTW INVESTMENTS, LP
- CIK
- CIK 1493215
- Filed
- Oct 26, 2020
- Reporting period
- Oct 16, 2020
- Description
- Schedule 13G beneficial ownership